Delgado-Calvo, K.; Lozano, E.; Briz, O.; Cives-Losada, C.; Marin, J.J.G.; Macias, R.I.R.
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs. Molecules 2025, 30, 3053.
https://doi.org/10.3390/molecules30143053
AMA Style
Delgado-Calvo K, Lozano E, Briz O, Cives-Losada C, Marin JJG, Macias RIR.
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs. Molecules. 2025; 30(14):3053.
https://doi.org/10.3390/molecules30143053
Chicago/Turabian Style
Delgado-Calvo, Kevin, Elisa Lozano, Oscar Briz, Candela Cives-Losada, Jose J. G. Marin, and Rocio I. R. Macias.
2025. "Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs" Molecules 30, no. 14: 3053.
https://doi.org/10.3390/molecules30143053
APA Style
Delgado-Calvo, K., Lozano, E., Briz, O., Cives-Losada, C., Marin, J. J. G., & Macias, R. I. R.
(2025). Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs. Molecules, 30(14), 3053.
https://doi.org/10.3390/molecules30143053